Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

Even after Trump’s new deal, obesity drugs are still too expensive.

President Donald Trump promises lower prices for weight loss drugs and reveals, one of his key staff members has a ...

GLP-1 drugs make it easier to lose weight, and to avoid associated serious health problems — and President Trump’s latest ...

A Novo Nordisk executive collapsed during President Trump’s announcement about lowering the cost of weight loss drugs like ...

A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

The list prices of obesity drugs Wegovy and Zepbound are over $1,000, but that's not necessarily what you pay.

Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...

US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices ...

Access to the drugs has been a consistent problem for patients because of their cost — around $500 a month for higher doses — ...

The deal offers popular weight loss drugs to be sold for as low as $149 on President Donald Trump's direct-to-consumer ...